(6R*,11AS*)-6-(HYDROXYMETHYL)-7,8,10-TRIMETHOXY-2,9-DIMETHYL-2,3,11,11A-TETRAHYDRO-1H-PYRAZINO-[1,2-B]-ISOQUINOLINE-1,4(6H)-DIONE
Compound with spectra: 1 NMR
![(6R*,11AS*)-6-(HYDROXYMETHYL)-7,8,10-TRIMETHOXY-2,9-DIMETHYL-2,3,11,11A-TETRAHYDRO-1H-PYRAZINO-[1,2-B]-ISOQUINOLINE-1,4(6H)-DIONE](/api/compound/APQWrhrKIs2.png?ph=true&h=300&w=458 "(6R*,11AS*)-6-(HYDROXYMETHYL)-7,8,10-TRIMETHOXY-2,9-DIMETHYL-2,3,11,11A-TETRAHYDRO-1H-PYRAZINO-[1,2-B]-ISOQUINOLINE-1,4(6H)-DIONE")
| SpectraBase Compound ID | APQWrhrKIs2 |
|---|---|
| InChI | InChI=1S/C18H24N2O6/c1-9-15(24-3)10-6-11-18(23)19(2)7-13(22)20(11)12(8-21)14(10)17(26-5)16(9)25-4/h11-12,21H,6-8H2,1-5H3/t11-,12-/m0/s1 |
| InChIKey | OLFCXFMACHWEHG-RYUDHWBXSA-N |
| Mol Weight | 364.4 g/mol |
| Molecular Formula | C18H24N2O6 |
| Exact Mass | 364.163436 g/mol |
| Enantiomer InChIKey | OLFCXFMACHWEHG-VXGBXAGGSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
4-Cyano-1,2,3,4,5,6-hydro-7,9,10-trimethoxy-3,8,11-trimethyl-1,5-imino-3-benzazocine
4,5,7-Trimethhoxy-2,3,6-trimethyl-2(2-methylbut-2-enoyl)indan-1-one
1-O-methyl-oureguattidine
Dragabine
(-)-STENANTHERINE
1-allyl-2-imino-10-methyl-3-(phenylsulfonyl)-1,2-dihydro-5H-dipyrido[1,2-a:2,3-d]pyrimidin-5-one
1-(heptylsulfanyl)-4-methyl-7,8-dihydro-6H-cyclopenta[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
UFDNTRJTAMHSLG-UHFFFAOYSA-N
N-(12,19-DIMETHOXY-13-NITROPODOCARPA-8,11,13-TRIEN-14-YL)-2,2,2-TRIFLUOROACETAMIDE
Orientine
| Title | Journal or Book | Year |
|---|---|---|
| Preparation of Tricyclic Lactam Model Compounds of Renieramycin and Saframycin Anticancer Natural Products from Common Intermediate | Chemical and Pharmaceutical Bulletin | 2013 |